The common sense model applied to hepatitis C

A qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception

Stella A. Safo, Abigail Batchelder, Deena Peyser, Alain H. Litwin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Hepatitis C virus (HCV) accounts for 15,000 deaths in the United States yearly because people living with HCV are not identified in time to seek treatment, are ineligible for or refuse treatment, or face structural impediments to obtaining treatment such as lack of access to health care or lack of insurance. People who inject drugs (PWID) comprise a large proportion-estimates of up to 60-70 %-of current and new HCV infected individuals and face many barriers to completing HCV treatment. Methods: We conducted 30 qualitative semi-structured interviews of current and former PWID seeking HCV treatment at an opioid-agonist treatment facility in New York City. We used thematic analysis, informed by grounded theory, to examine perceptions of HCV and decisions to initiate HCV treatment. We analyzed the themes that emerged via the common sense model (CSM) of illness perception theoretical framework. Results: Using thematic analyses, two major themes emerged related to engagement in HCV treatment. First, participants independently compared HCV to HIV, and in so doing, emphasized the potential fatality of HCV and the need for treatment. Second, participants described witnessing others suffer or die from untreated HCV and expressed how these recollections impacted their desire to undergo treatment themselves. Together, these themes contributed to the way participants perceived HCV and informed their decisions to initiate treatment. Both themes reflect the CSM's "self-regulation" process, which posits that understanding the causes and consequences of an illness impacts one's ability to seek treatment to overcome this illness state. Conclusions: This paper offers insight into how clinicians can better understand and utilize HCV illness perceptions to evaluate willingness to engage in HCV treatment among PWID considering antiviral treatment modalities.

Original languageEnglish (US)
Article number20
JournalHarm Reduction Journal
Volume12
Issue number1
DOIs
StatePublished - Jun 20 2015

Fingerprint

Hepatitis C
Hepacivirus
Health Services Accessibility
Aptitude
Insurance
Pharmaceutical Preparations
Opioid Analgesics
Antiviral Agents

Keywords

  • Hepatitis C (HCV)
  • HIV/AIDS
  • Illness perception
  • People who inject drugs (PWID)
  • Substance use
  • Treatment barriers

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health

Cite this

The common sense model applied to hepatitis C : A qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception. / Safo, Stella A.; Batchelder, Abigail; Peyser, Deena; Litwin, Alain H.

In: Harm Reduction Journal, Vol. 12, No. 1, 20, 20.06.2015.

Research output: Contribution to journalArticle

@article{fa2c88bf73054e84b73ef2be729c411f,
title = "The common sense model applied to hepatitis C: A qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception",
abstract = "Background: Hepatitis C virus (HCV) accounts for 15,000 deaths in the United States yearly because people living with HCV are not identified in time to seek treatment, are ineligible for or refuse treatment, or face structural impediments to obtaining treatment such as lack of access to health care or lack of insurance. People who inject drugs (PWID) comprise a large proportion-estimates of up to 60-70 {\%}-of current and new HCV infected individuals and face many barriers to completing HCV treatment. Methods: We conducted 30 qualitative semi-structured interviews of current and former PWID seeking HCV treatment at an opioid-agonist treatment facility in New York City. We used thematic analysis, informed by grounded theory, to examine perceptions of HCV and decisions to initiate HCV treatment. We analyzed the themes that emerged via the common sense model (CSM) of illness perception theoretical framework. Results: Using thematic analyses, two major themes emerged related to engagement in HCV treatment. First, participants independently compared HCV to HIV, and in so doing, emphasized the potential fatality of HCV and the need for treatment. Second, participants described witnessing others suffer or die from untreated HCV and expressed how these recollections impacted their desire to undergo treatment themselves. Together, these themes contributed to the way participants perceived HCV and informed their decisions to initiate treatment. Both themes reflect the CSM's {"}self-regulation{"} process, which posits that understanding the causes and consequences of an illness impacts one's ability to seek treatment to overcome this illness state. Conclusions: This paper offers insight into how clinicians can better understand and utilize HCV illness perceptions to evaluate willingness to engage in HCV treatment among PWID considering antiviral treatment modalities.",
keywords = "Hepatitis C (HCV), HIV/AIDS, Illness perception, People who inject drugs (PWID), Substance use, Treatment barriers",
author = "Safo, {Stella A.} and Abigail Batchelder and Deena Peyser and Litwin, {Alain H.}",
year = "2015",
month = "6",
day = "20",
doi = "10.1186/s12954-015-0054-1",
language = "English (US)",
volume = "12",
journal = "Harm Reduction Journal",
issn = "1477-7517",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The common sense model applied to hepatitis C

T2 - A qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception

AU - Safo, Stella A.

AU - Batchelder, Abigail

AU - Peyser, Deena

AU - Litwin, Alain H.

PY - 2015/6/20

Y1 - 2015/6/20

N2 - Background: Hepatitis C virus (HCV) accounts for 15,000 deaths in the United States yearly because people living with HCV are not identified in time to seek treatment, are ineligible for or refuse treatment, or face structural impediments to obtaining treatment such as lack of access to health care or lack of insurance. People who inject drugs (PWID) comprise a large proportion-estimates of up to 60-70 %-of current and new HCV infected individuals and face many barriers to completing HCV treatment. Methods: We conducted 30 qualitative semi-structured interviews of current and former PWID seeking HCV treatment at an opioid-agonist treatment facility in New York City. We used thematic analysis, informed by grounded theory, to examine perceptions of HCV and decisions to initiate HCV treatment. We analyzed the themes that emerged via the common sense model (CSM) of illness perception theoretical framework. Results: Using thematic analyses, two major themes emerged related to engagement in HCV treatment. First, participants independently compared HCV to HIV, and in so doing, emphasized the potential fatality of HCV and the need for treatment. Second, participants described witnessing others suffer or die from untreated HCV and expressed how these recollections impacted their desire to undergo treatment themselves. Together, these themes contributed to the way participants perceived HCV and informed their decisions to initiate treatment. Both themes reflect the CSM's "self-regulation" process, which posits that understanding the causes and consequences of an illness impacts one's ability to seek treatment to overcome this illness state. Conclusions: This paper offers insight into how clinicians can better understand and utilize HCV illness perceptions to evaluate willingness to engage in HCV treatment among PWID considering antiviral treatment modalities.

AB - Background: Hepatitis C virus (HCV) accounts for 15,000 deaths in the United States yearly because people living with HCV are not identified in time to seek treatment, are ineligible for or refuse treatment, or face structural impediments to obtaining treatment such as lack of access to health care or lack of insurance. People who inject drugs (PWID) comprise a large proportion-estimates of up to 60-70 %-of current and new HCV infected individuals and face many barriers to completing HCV treatment. Methods: We conducted 30 qualitative semi-structured interviews of current and former PWID seeking HCV treatment at an opioid-agonist treatment facility in New York City. We used thematic analysis, informed by grounded theory, to examine perceptions of HCV and decisions to initiate HCV treatment. We analyzed the themes that emerged via the common sense model (CSM) of illness perception theoretical framework. Results: Using thematic analyses, two major themes emerged related to engagement in HCV treatment. First, participants independently compared HCV to HIV, and in so doing, emphasized the potential fatality of HCV and the need for treatment. Second, participants described witnessing others suffer or die from untreated HCV and expressed how these recollections impacted their desire to undergo treatment themselves. Together, these themes contributed to the way participants perceived HCV and informed their decisions to initiate treatment. Both themes reflect the CSM's "self-regulation" process, which posits that understanding the causes and consequences of an illness impacts one's ability to seek treatment to overcome this illness state. Conclusions: This paper offers insight into how clinicians can better understand and utilize HCV illness perceptions to evaluate willingness to engage in HCV treatment among PWID considering antiviral treatment modalities.

KW - Hepatitis C (HCV)

KW - HIV/AIDS

KW - Illness perception

KW - People who inject drugs (PWID)

KW - Substance use

KW - Treatment barriers

UR - http://www.scopus.com/inward/record.url?scp=84932601361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932601361&partnerID=8YFLogxK

U2 - 10.1186/s12954-015-0054-1

DO - 10.1186/s12954-015-0054-1

M3 - Article

VL - 12

JO - Harm Reduction Journal

JF - Harm Reduction Journal

SN - 1477-7517

IS - 1

M1 - 20

ER -